A technique has been developed for the measurement of kallikrein 'production' in rat renal cortical cells in suspension.
Introduction
Urinary kallikrein (kininogenin, EC 3.4.21.8) excretion is abnormal in humans (Margolius, Geller, Pisano & Sjoerdsma, 1971 ) and rats (Margolius, Geller, De Jong, Pisano & Sjoerdsma, 1972 ) with hypertension. Although many factors may regulate kallikrein excretion, it is probable that aldosterone is a major regulatory influence. Low dietary sodium (Geller, Margolius, Pisano & Kieser, 1972; Margolius, Horwitz, Geller, Alexander, Gill, Pisano & Keiser, 1974a) or high dietary potassium (Horwitz, Margolius, & Keiser, 1975) increase urinary kallikrein excretion. Administration of deoxycorticosterone to rats (Geller et af., 1972) or fludrocortisone to man (Adetuyibi & Mills, 1972 Margolius, unpublished work) . Finally, a specific aldosterone antagonist, spironolactone, decreases kallikrein excretion in normal human subjects, as well as in patients with primary aldosteronism (Margolius et al., 1974a, b) . The present study was designed to determine whether changes in urinary kallikrein excretion induced by aldosterone or spironolactone are a direct reflection of events within renal cells.
Methods
Suspensions of renal cortical cells from the kidneys of male Sprague-Dawley rats were prepared according to the method of Kaizu & Margolius (1975 Tos-Arg-OMe esterase activity from rat renal cortical cells was identified as kallikrein by comparison with purified rat urinary (specific activity 14.0 units/A2ao) and rat kidney (specific activity 2.1 units/AZa0) kallikrein for pH optima, the effects of aprotinin (Trasylol), soya bean, lima bean and ovomucoid trypsin inhibitors, double-diffusion analysis (Ouchterlony, 1958) and biological activity by bioassay with the guinea-pig ileum (Webster & Prado, 1970) .
Pooled renal cortical cell suspensions of sixteen kidneys from eight rats were made. Equal numbers of cells (6.0 x lo8) were incubated in 1.0 ml of a medium (Stanners et al., 1971) for either 3 or 8 h under 0 2 / C 0 2 (95:5) at 37°C in 5.0 ml plastic culture tubes. Kallikrein esterase activity was measured in both the cells and the supernatant medium in control suspensions and suspensions exposed to aldosterone (6.1 x 10-'-3.1 x mol/l) or spironolactone (4.3 x 10-5-2.2 x mol/l).
Results
The mean cell number for each renal cortex obtained from the twenty-four kidneys of twelve normal rats was 5 . 7~ lo8 cells (range 3 . 0~ lo8 to 1 1 . 0~ lo8 cells/renal cortex). Of the Tos-Arg-OMe esterase activity 70% was eluted as a single peak on DEAEcellulose at a concentration corresponding to about 0.20 mol/l NaC1/0.01 mol/l sodium phosphate, pH 7.0. The pH optimum for Tos-Arg-OMe hydrolysis by the major renal cortical cell Tos-Arg-OMe esterase was 9.0 and was identical with that of rat kidney kallikrein and rat urinary kallikrein. The Tos-Arg-OMe esterase activity of the cortical cell esterase and the standard kallikrein preparations was completely inhibited by aprotinin, strongly inhibited by soya bean trypsin inhibitor, but not inhibited by either lima bean or ovomucoid trypsin inhibitors. Double-diffusion analysis with an undiluted antiserum (antibody titre approx. 2 mg/ml) (Nustad & Pierce, 1974) to rat urinary kallikrein gave a single line of identity with rat urinary kallikrein and the renal cortical cell Tos-Arg-OMe esterase. Renal cortical cell Tos-Arg-OMe esterase released kinin from heated dog plasma equivalent to 1-5 ng of bradykinin and caused a slow contraction of the guinea-pig ileum, abolished by carboxypeptidase B. Esterase activity ranged from 15.8 x unit per kidney cortex homogenate in five separate experiments. The yield of rat renal cortical cell kallikrein after DEAE-cellulose chromatography ranged from 7.1 x to 46.9 x lo-' unit (40-110%, mean 70%). Recovery of added known amounts of purified rat urinary kallikrein to cell homogenates, applied to the DEAE-cellulose columns or added to the DEAE-cellulose column fractions before assay, averaged 83, 97 and 108% respectively. In nine separate kidneys, the amount of rat renal cortical cell kallikrein esterase activity ranged from 3.2 x to 46.9 x unitlrenal cortex (1.2-1.6 g wet weight). Bioassay of five of these samples resulted in good agreement in the majority of the samples. The calculated amounts of rat renal cortical cell kallikrein esterase activity ranged from 0.6 x 10-l o to 4.6 x 10-In contrast, in four experiments, each of which involved suspensions of renal cortical cells from the sixteen kidneys of eight normal rats, kallikrein could not be detected intracellularly under the present incubation conditions. However, in a representative experiment, the medium surrounding duplicate suspensions of 6.0 x lo8 (approximately 1 .O ml) cells obtained from sixteen kidneys of eight normal rats, kallikrein activity was 39.0 x unit after 3 and 8 h of incubation respectively. Addition of aldosterone, 6.1 x mol/l, to the medium at the onset of the incubation period resulted in an increase in kallikrein esterase activity to 45.1 x unit after 3 and 8 h 
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of incubation respectively. Aldosterone, 3-1 x lo-* mol/l, increased kallikrein activity in the medium to 51.3 x and 161.6 x (+223%) unit after 3 and 8 h of incubation. Spironolactone. 4.3 x mol/l, added to the medium at the onset of the incubation period, resulted in a decrease in kallikrein activity to 19.5 x and 38.3 x unit after 3 and 8 h of incubation respectively. Spironolactone, 2.2 x lo-* mol/l, further decreased extracellular kallikrein concentration to 13.5 x lo-' and 30-0 x unit after 3 and 8 h of incubation.
Discussion
We have isolated and measured a renal cortical cell Tos-Arg-OMe esterase within non-incubated rat renal cortical cells and in media surrounding incubated cells in suspension. The Tos-Arg-OMe esterase appears to be identical with rat urinary or kidney kallikrein in pH optima, effects of inhibitors and the ability to release a biologically active kinin from substrate. There was also immunological identity between this esterase and a purified rat urinary kallikrein when an antiserum obtained to the latter was used. Thus this renal cortical cell Tos-Arg-OMe esterase appears to be a kallikrein within and around a heterogeneous population of viable renal cortical cells in suspension. Cells suspended in media and incubated under 02/C02 for 3-8 h showed no detectable kallikrein activity intracellularly, whereas extracellular activities were measurable. Furthermore, addition of aldosterone caused an increase and spironolactone a decrease in extracellular kallikrein activity. Although the concentrations of aldosterone or spironolactone used in the present study were extremely high, these findings are consistent with the observations that aldosterone or other mineralocorticoids increase kallikrein excretion in human and rat urine, whereas spironolactone, a specific aldosterone antagonist, decreases kallikrein excretion. These data suggest that changes in urinary kallikrein excretion caused by mineralocorticoids and an antagonist in man and animals reflect changes in renal cellular kallikrein production. Low to absent kallikrein excretion occurs in adrenalectomized rats (Geller et al., 1972) and the results of this study suggest that renal kallikrein production could be mineralocorticoid-dependent . These changes in production could represent altered release or degradation of the enzyme, but might suggest changes in kallikrein synthesis, raising the possibility that synthesis is a mineralocorticoid-dependent process.
The role of the renal kallikrein-kinin system is unclear. Fig. 1 shows one hypothesis on the role of kallikrein in the distal portion of the nephron. It is based upon the observed relationships between kallikrein and mineralocorticoids in man, animals and the data from isolated renal cortical cells reported here. Kallikrein could be an aldosterone, Ro. I . Some possible roles for the enzyme kallikrein within the distal nephron.
induced protein directly involved in the mechanism of the antinatriuretic action of aldosterone and the natriuretic actions of spironolactone. Kallikrein synthesis stimulated by aldosterone could result in the local production of a kinin, which acts either to affect membrane permeability to sodium, available energy for the sodium pump, or the sodium pump directly. Recent stop-flow studies in the dog (Carretero & Scicli, 1976) seem to show that kallikrein enters the urine in the distal nephron, and Ward, Gedney, Dowben & Erdos (1975) have shown renal kallikrein to be bound to plasma membranes that seem to be of distal tubular origin. In addition, recent studies (C. Takeguchi, G. L. Lindenmayer & H. S. Margolius, unpublished work) have failed to show any effect of kinins on renal sodium-potassiumdependent adenosine triphosphatase activity. Collectively, the data suggest that if kallikrein were an aldosterone-induced protein, it would act upon kininogen within the cell or available in tubular fluid to generate a kinin which could then function as an ionophore or permease, increasing the influx of sodium from tubule to cell. In addition, this locally generated kinin may act to increase the activity of prostaglandin synthetase at a more distal site (McGiff, Itskovitz, Terragno & Wong, 1976) in the renal medulla resulting in the generation of prostaglandin Ez. Prostaglandin Ez produced at that site would also function as an antinatriuretic substance. Support for this portion of our hypothesis is derived from the data of Gill, Alexander, Halushka, Pisano & Keiser (1975) , who showed that inhibition of prostaglandin synthesis by indomethacin in hypophysectomized dogs resulted in inhibition of distal nephron sodium reabsorption. Similarly, either meclofenamate or the competitive prostaglandin inhibitor RO 20-5720 given to unanaesthetized dogs also resulted in a natriuresis without changes in urinary volume or potassium excretion during water diuresis, suggesting that the resultant natriuresis was due to diminished sodium reabsorption beyond the distal tubule (Kirschenbaum & Stein, 1976) . These data are compatible with those of Lipson & Sharp (1971) . who showed that the application of prostaglandin E2 to the serosal side of the toad bladder increased short-circuit current and sodium transport.
Although other possible explanations exist for the gathered data, we think this hypothesis is simple and susceptible of disproof. Studies are under way to determine whether or not kallikrein is an aldosterone-induced protein. The possibility that it is raises many questions about abnormal kallikrein excretion in hypertension, especially in those patients with essential hypertension having low or absent urinary kallikrein excretion.
